Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

CANTALOUPE, INC. (CTLP)

  • SEC News
  • May 08, 2026, 10:36 UTC
  • 5
  • 0 comments

New Form 25-NSE - CANTALOUPE, INC. <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0001354457-26-000420 <b>Size:</b> 3 KB

Comment Full text

TSH RESOURCES BERHAD (TSH)

  • SEC News
  • May 08, 2026, 10:35 UTC
  • 5
  • 0 comments

General Announcement: Share Buy-Back

Comment Full text

INTERFACE INC (TILE)

  • SEC News
  • May 08, 2026, 10:35 UTC
  • 5
  • 1 comments

(30% Negative) INTERFACE INC (TILE) Reports Q2 2026 Financial Results

Comment Full text

SINO GRANDNESS FOOD INDUSTRY GROUP LIMITED (T4B)

  • SEC News
  • May 08, 2026, 10:35 UTC
  • 5
  • 0 comments

General Announcement: MINUTES OF EXTRAORDINARY GENERAL MEETING

Comment Full text

AIRSCULPT TECHNOLOGIES, INC. (AIRS)

  • SEC News
  • May 08, 2026, 10:35 UTC
  • 5
  • 1 comments

(30% Negative) AIRSCULPT TECHNOLOGIES, INC. (AIRS) Reports Q2 2026 Financial Results

Comment Full text

JPMORGAN CHASE & CO (JPM)

  • SEC News
  • May 08, 2026, 10:35 UTC
  • 5
  • 0 comments

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0001918704-26-012525 <b>Size:</b> 621 KB

Comment Full text

THAI BEVERAGE PUBLIC CO LTD (Y92)

  • SEC News
  • May 08, 2026, 10:35 UTC
  • 5
  • 0 comments

Financial Statements and Related Announcement: Notification of Results Release

Comment Full text

A-SONIC AEROSPACE LIMITED (BTJ)

  • SEC News
  • May 08, 2026, 10:34 UTC
  • 5
  • 0 comments

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of interest/ Changes in interest of Directors/ Chief Executive Officer

Comment Full text

OXLEY HOLDINGS LIMITED (5UX)

  • SEC News
  • May 08, 2026, 10:34 UTC
  • 5
  • 0 comments

Share Buy Back - Daily Share Buy-Back Notice: Daily Share Buy-Back Notice

Comment Full text

GOLDMAN SACHS GROUP INC (GS)

  • SEC News
  • May 08, 2026, 10:34 UTC
  • 3
  • 0 comments

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0001193125-26-213509 <b>Size:</b> 765 KB

Comment Full text
  • Previous
  • 1472
  • 1473
  • 1474
  • 1475
  • 1476
  • Next

Search

News categories

  • Technical Exchange News(12517)
  • Event(6229)
  • SEC News(286741)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(162348)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin